MeSH Review:
Insurance, Health, Reimbursement
- The impact of losartan on the lifetime incidence of ESRD and costs in Mexico. Arredondo, A., Burke, T.A., Carides, G.W., Lemus, E., Querol, J. Rev. Invest. Clin. (2005)
- Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database. Adams, P.C., Gregor, J.C., Kertesz, A.E., Valberg, L.S. Gastroenterology (1995)
- The cost-effectiveness of sildenafil. Smith, K.J., Roberts, M.S. Ann. Intern. Med. (2000)
- Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis. Bapat, B., Noorani, H., Cohen, Z., Berk, T., Mitri, A., Gallie, B., Pritzker, K., Gallinger, S., Detsky, A.S. Gut (1999)
- Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists. Creticos, P.S. Drugs (2003)
- Consumer-driven health care: just a tweak or a revolution? Scandlen, G. Health affairs (Project Hope) (2005)
- A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Dubinsky, M.C., Reyes, E., Ofman, J., Chiou, C.F., Wade, S., Sandborn, W.J. Am. J. Gastroenterol. (2005)
- Benzodiazepine tranquilizers and the risk of accidental injury. Oster, G., Huse, D.M., Adams, S.F., Imbimbo, J., Russell, M.W. American journal of public health. (1990)
- Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation. Thistlethwaite, J.R., Haag, B.W., Jones, K.W., Stuart, J.K., Stuart, F.P. Hum. Immunol. (1985)
- A pharmacoeconomic analysis of topical therapies for patients with mild-to-moderate stable plaque psoriasis: a US study. Marchetti, A., LaPensee, K., An, P. Clinical therapeutics. (1998)
- Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma. Volmer, T., Kielhorn, A., Weber, H.H., Wiessmann, K.J. PharmacoEconomics. (1999)
- Alteplase: a pharmacoeconomic evaluation of its use in the management of myocardial infarction. Barradell, L.B., Goa, K.L. PharmacoEconomics. (1995)
- A review of the economic burden of ADHD. Matza, L.S., Paramore, C., Prasad, M. Cost effectiveness and resource allocation [electronic resource] : C/E. (2005)
- Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Finkelstein, B.S., Imperiale, T.F., Speroff, T., Marrero, U., Radcliffe, D.J., Cuttler, L. Archives of pediatrics & adolescent medicine. (2002)
- Barriers to successful dietary control among pregnant women with phenylketonuria. Brown, A.S., Fernhoff, P.M., Waisbren, S.E., Frazier, D.M., Singh, R., Rohr, F., Morris, J.M., Kenneson, A., MacDonald, P., Gwinn, M., Honein, M., Rasmussen, S.A. Genet. Med. (2002)
- Policy issues related to prospective payment for pediatric hospitalization. Payne, S.M., Restuccia, J.D. Health care financing review. (1987)
- Home parenteral nutrition: a hospital-based program with commercial logistic support. Wesley, J.R., Khalidi, N., Faubion, W.C., Ryan, M.L., de Leon, R.F. JPEN. Journal of parenteral and enteral nutrition. (1984)
- Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective. de Lissovoy, G., Subedi, P. The American journal of managed care. (2002)